Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
(NASDAQ: STRO) Delayed: 15.34 -0.14 (0.9%)
Previous Close $15.48    52 Week High $ 
Open $15.58    52 Week Low $ 
Day High $15.58    P/E N/A 
Day Low $14.81    EPS $ 
Volume 651,375